fda category 2 bulk drug substances bpc-157 compounding list considers adding a dozen peptides to its RFK Jr.'s peptide push could
RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion Industry Update: Interim 503A and 503B Bulks Lists New Revisions Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3




